Molecular Chaperones in Cancer and Protein Quality Control Frontiers in Immunomodulation and Cancer Therapy (2nd edition)

Home | Events | Seminars | Page 2

For these events, a scientist of international standing is invited to conduct a seminar or otherwise interact with the CNIO’s team of researchers. Several of these are scheduled over the course of the year and are open to the public. Participants come from different fields, literature and technology included. The aim is to create a stimulating environment that helps to clear minds of stale thoughts and replace them with new ideas.

Women in Science Office Seminar 07/03/2024
Clara Montoya
Ignotas y Resueltas (this seminar will be held in Spanish)
Ad Hoc Seminar 06/03/2024
Francisco M. Barriga
Dissecting the Function of Copy Number Alterations in Cancer
Ad Hoc Seminar 29/02/2024
Basil Greber
High-resolution structures of the human CDK-activating kinase bound to inhibitors: Harnessing the power of cryo-EM for discovery of cancer therapeutics
Ad Hoc Seminar 26/02/2024
Jacky Goetz
Intravascular Forces shape Tumor Metastasis
Distinguished Seminar 23/02/2024
Sjors Scheres
Molecular pathology of neurodegenerative diseases by cryo-EM of amyloids
Distinguished Seminar 16/02/2024
Mariam Jamal-Hanjani
Insights into lung cancer evolution and metastasis in TRACERx and PEACE
Distinguished Seminar 09/02/2024
Cristina Mayor
Targeted protein degradation: drug discovery opportunities & overcoming resistance mechanisms in cancer
Women in Science Office Seminar 09/01/2024
H.E. Dr. Sarmila Parajuli Dhakal
Bridging Borders Through Science: Insights from Nepal
Ad Hoc Seminar 04/01/2024
Miguel Bernabé Rubio
Mechanical factors induce Myc-dependent dedifferentiation of adult epidermal cells
Ad Hoc Seminar 19/12/2023
Roger Castells-Graells
Engineered Protein Cages for Imaging of Small Proteins by Cryo-EM
Distinguished Seminar 15/12/2023
Victoria Sanz-Moreno
Finding vulnerabilities in metastatic cancer cells
Distinguished Seminar 01/12/2023
Stefan Knapp
Targeting strategies for the development of highly selective allosteric and orthosteric kinase inhibitors

Up